Background: Resveratrol is a natural polyphenolic compound and its anticancer effect has been receiving considerable attention. Previous studies showed that resveratrol could inhibited the growth of human gastric carcinoma cells and apoptosis induction was an important mechanism. However, whether mitochondrial pathway was involved in resveratrol-induced apoptosis in human gastric cancer was not very clear.
Methods: The cells were examined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay, Annexin V/PI staining assay, mitochondrial membrane depolarization, cell morphological assessment, cytochrome c release assay, and Western blotting assay.
Results: In this study, we found that resveratrol induced apoptosis in human gastric carcinoma SGC-7901 cells. Cleaved PARP was observed and caspase-3 was activated by resveratrol. Next, the mitochondrial membrane potential of cells dissipated after the cells were treated by resveratrol. Moreover, we found that pro-caspase 9 was downregulated and cytochrome c released from mitochondrial to the cytosol. We also found that the expression ratio of Bax/Bcl-2 was increased in the treated cells. We finally showed that resveratrol inhibited the proliferation of SGC-7901 xerograph in vivo.
Conclusions: Collectively, our findings demonstrate that resveratrol triggers apoptosis via mitochondrial pathway in SGC-7901 cells, which provide more basis for resveratrol acting as antitumor agents in cancer therapy.
Keywords: apoptosis; mitochondrial pathway; resveratrol.
© 2018 John Wiley & Sons Australia, Ltd.